Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,166,093
+$1,788,406 QoQ
Shares Held
403,324
+2.2% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 17%
Shared 83%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ABCL ranks #41 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in ABCL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,166,093 | 403,324 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,377,687 | 394,753 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,278,585 | 373,856 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,534,937 | 503,964 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,385,431 | 403,916 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $863,078 | 387,031 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $1,192,483 | 406,991 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,059,197 | 407,384 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,210,266 | 408,874 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $1,777,376 | 392,357 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $2,216,158 | 388,119 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,815,168 | 394,602 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,151,476 | 487,845 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,680,504 | 1,151,261 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,290,024 | 1,114,514 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,764,994 | 1,088,473 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,068,469 | 757,603 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,066,104 | 827,293 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,074,374 | 844,362 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,737,458 | 186,500 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,378,694 | 153,577 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,268,255 | 66,792 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $123,576 | 3,071 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||